New Measure of Adherence Adjusted for Prescription Patterns: The Case of Adults with Asthma Treated with Inhaled Corticosteroid Monotherapy

Author:

Blais Lucie1,Kettani Fatima-Zohra2,Beauchesne Marie-France3,eGre Catherine Lemi4,Perreault Sylvie3,Forget Amélie4

Affiliation:

1. Faculté of Pharmacy, Université de Montréal, Montréal, Québec, Canada

2. Research Center, Hôpital du Sacré-Coeur de Montréal, Montréal

3. Faculté of Pharmacy, Université de Montréal

4. Research Center, Hôpital du Sacré-Coeur de Montréal

Abstract

Background: Common measures of adherence to prescribed medications derived from administrative databases reflect both patients’ and physicians’ behavior, even if the measures are often interpreted as reflecting only the patient's adherence. Adherence to inhaled corticosteroids (ICSs) has been shown to be low among patients with asthma. Objective: To develop a new measure of patients’ adherence adjusted for prescription patterns and to evaluate the extent to which the low use of ICSs in asthma is due to patients’ nonadherent or suboptimal prescribing practices. Methods: The new measure of adherence, called the proportion of prescribed days covered (PPDC), is defined as the ratio of the total days’ supply dispensed to the total days’ supply prescribed during the study period. The PPDC is a modification of an existing adherence measure, the proportion of days covered (PDC). The PPDC and PDC for ICSs, therapy that should be prescribed for chronic daily use to patients with persistent asthma, were compared within a cohort of 4190 ICS-naïve patients with asthma aged 18-45 years derived from the administrative health databases of Quebec. Canada. We estimated the mean and the 95% confidence interval of the PPDC and PDC for ICSs over 1 year, and we calculated the part of nonadherence attributed to patients when measured with the PDC that can be attributed to nonoptimal prescribing of ICSs for chronic daily use with the following formula: [(1 – PDC) – (1 – PPDC)] / (1 – PDC). Results: The mean PPDC and PDC during the 1 -year study were 52.6% (95% CI 51.6 to 53.6) and 19.1% (95% CI 18.6 to 19.6), respectively. Forty-one percent of nonadherence attributed to patients when measured with the PDC could be, in fact, attributed to non prescribing of ICSs (or chronic daily use. Conclusions: Our new adherence measure, the PPDC, may be considered as another way to assess patient adherence, taking into account differing prescribing patterns.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3